GOSSAMER BIO, INC. (GOSS) Provides Business Update
GOSSAMER BIO, INC. (GOSS) issued a business update covering recent developments.
🔍 Detailed Event Analysis:
AI Summary: Announces Final Tender Results for Exchange Offer and Consent Solicitation with Respect to Existing Convertible NotesSan Diego, California. 1 2 goss-20260617xexx991xprfin. 00% Convertible Senior Notes due 2027 (the “Existing Convertible Notes”) for a pro rata portion of (i) up to $72.
Key Elements Identified:
Drugs/Compounds: million
Diseases/Conditions: aggregate principal amount of its new 7
Organizations: Common Stock, the “Common Stock, the “Exchange Offer
📋 GOSSAMER BIO, INC. (GOSS) - Other Event
Filing Date: 2026-06-17
Accepted: 2026-06-17 08:01:14
Event Type: Other Event
Event Details:
🔍 Detailed Event Analysis:
AI Summary: Announces Final Tender Results for Exchange Offer and Consent Solicitation with Respect to Existing Convertible NotesSan Diego, California. 1 2 goss-20260617xexx991xprfin. 00% Convertible Senior Notes due 2027 (the “Existing Convertible Notes”) for a pro rata portion of (i) up to $72.
Key Elements Identified:
💼 Business Developments:
No business developments data available.
Structured Data: